Cancer vaccine - CEL-SCI/Max Delbruck Center

Drug Profile

Cancer vaccine - CEL-SCI/Max Delbruck Center

Alternative Names: Breast cancer vaccine - CEL-SCI/Max Delbruck Center; Colon cancer vaccine - CEL-SCI/Max Delbruck Center

Latest Information Update: 27 Oct 2014

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator CEL-SCI Corporation; Nonindustrial source
  • Class Cancer vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Discontinued Breast cancer; Colorectal cancer

Most Recent Events

  • 22 Nov 1999 New profile
  • 22 Nov 1999 Preclinical development for Breast cancer in Germany (Parenteral)
  • 22 Nov 1999 Preclinical development for Colorectal cancer in Germany (Parenteral)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top